NCT01065051View on ClinicalTrials.gov

Hemodynamic and Echocardiographic Assessment of Riociguat Effects on Myocardial Wall Contractility and Relaxation Kinetics

PHASE2TerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Hypertension, PulmonaryVentricular Dysfunction, Left
Interventions
DRUG

Riociguat (Adempas, BAY63-2521)

1 mg single oral dose

DRUG

Placebo

Single oral dose

Trial Locations (2)

55905

Rochester

02114-2696

Boston

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY